Become An AI Expert In Just 5 Minutes
If you’re a decision maker at your company, you need to be on the bleeding edge of, well, everything. But before you go signing up for seminars, conferences, lunch ‘n learns, and all that jazz, just know there’s a far better (and simpler) way: Subscribing to The Deep View.
This daily newsletter condenses everything you need to know about the latest and greatest AI developments into a 5-minute read. Squeeze it into your morning coffee break and before you know it, you’ll be an expert too.
Subscribe right here. It’s totally free, wildly informative, and trusted by 600,000+ readers at Google, Meta, Microsoft, and beyond.
Welcome back, DERM Community.
Last week, we explored ingredient interactions and how strategic combinations drive better outcomes than single-agent approaches.
This week, we're addressing something that walks into the clinic far more often than it appears in medical literature: underarm darkening.
Here's the disconnect:
Patients present asking for "lightening creams" or blaming their deodorant choice.
Providers often default to topical hydroquinone or a dismissive "it's cosmetic."
But axillary hyperpigmentation is rarely that simple and when we miss the underlying driver, treatment fails.
Let's talk about the five clinical mistakes that keep this condition undertreated and misunderstood.
The 5 Clinical Mistakes in Treating Underarm Hyperpigmentation
1. Assuming It's All Post-Inflammatory Hyperpigmentation (PIH)
The reflexive diagnosis is PIH from shaving, friction, or irritating deodorants.
And yes, mechanical trauma is common.
But not every case of axillary darkening is post-inflammatory.
Three distinct patterns present differently:
Acanthosis nigricans (AN):
Velvety, thickened texture
Often bilateral and symmetric
Associated with insulin resistance, PCOS, obesity, or rarely, malignancy
Responds poorly to depigmenting agents alone
Post-inflammatory hyperpigmentation:
Flat or slightly raised
History of irritation, folliculitis, or trauma
Responds to topical depigmenting agents and barrier repair
Friction melanosis:
Chronic mechanical stress (tight clothing, repetitive motion)
More common in athletes or people with occupations involving repetitive arm movement
Improves with friction reduction + gentle exfoliation
The mistake: Treating them all the same.
The fix: Pattern recognition drives treatment. Texture matters as much as color.
2. Missing the Metabolic Signal
When acanthosis nigricans appears in the axillae, it's often part of a larger picture.
Axillary AN is a cutaneous marker of:
Insulin resistance (most common)
Prediabetes or type 2 diabetes
Polycystic ovary syndrome (PCOS)
Metabolic syndrome
Rarely: gastric adenocarcinoma or other internal malignancy (malignant AN)
The mistake: Treating the skin without addressing systemic health.
The fix: When you see velvety, hyperpigmented plaques in the axillae (especially with neck involvement), check:
Fasting glucose and HbA1c
Fasting insulin (if available)
Lipid panel
Consider PCOS workup in reproductive-age women with irregular cycles
Topical therapy alone won't resolve metabolically-driven AN. Metformin, weight management, and lifestyle modification improve the skin by improving insulin sensitivity.
Clinical pearl: If axillary AN appears suddenly in a patient over 40 with no metabolic risk factors, rule out paraneoplastic syndrome.
3. Overprescribing Hydroquinone Without Context
Hydroquinone is the first-line depigmenting agent for melasma and PIH.
But axillary skin is:
Occluded
Prone to irritation
Subject to friction
Sensitive to high-potency agents
The mistake: Prescribing 4% hydroquinone indefinitely without counseling on application, duration, or risks.
The fix: Structure the approach:
For PIH-driven axillary darkening:
Start with gentler agents: azelaic acid 15-20%, kojic acid, or alpha arbutin
Reserve hydroquinone for refractory cases
Limit hydroquinone to 12-16 weeks maximum (risk of ochronosis with prolonged use, especially in darker skin types)
Apply to completely dry skin to minimize irritation
Always pair with barrier repair (niacinamide, ceramides)
For acanthosis nigricans:
Hydroquinone has limited efficacy because the issue is epidermal thickening, not just melanin
Better options: topical retinoids (tretinoin 0.025-0.05%) to normalize keratinization, or keratolytics like urea 20-40% or salicylic acid
Clinical pearl: In Fitzpatrick IV-VI skin, prolonged hydroquinone use in occluded areas (like axillae) increases risk of exogenous ochronosis. Use with caution and clear timelines.
4. Ignoring the Role of Contact Dermatitis
Many patients with axillary darkening have a history of:
Allergic or irritant contact dermatitis from deodorants/antiperspirants
Chronic low-grade inflammation that triggers melanin production
Secondary lichenification from scratching or rubbing
Common culprits:
Fragrance (top allergen in personal care products)
Propylene glycol
Aluminum compounds in antiperspirants
Baking soda in "natural" deodorants (high pH causes irritation)
Essential oils marketed as "gentle" alternatives
The mistake: Prescribing depigmenting agents without removing the inflammatory trigger.
The fix:
Take a detailed product history. Ask specifically: "What deodorant or antiperspirant do you use?"
Recommend fragrance-free, dye-free, low-pH formulations
Consider patch testing if history suggests contact allergy
Treat any active dermatitis (topical corticosteroid taper if needed) before introducing depigmenting agents
You can't lighten inflamed skin effectively. Calm first, then treat pigmentation.
5. Failing to Address Mechanical Triggers
Even with excellent topical therapy, darkening will persist if friction and irritation continue.
Common mechanical triggers:
Daily shaving (causes microtrauma and inflammation)
Waxing or plucking (folliculitis → PIH)
Tight-fitting clothing or bras that rub constantly
Excessive scrubbing with loofahs or harsh exfoliants
The mistake: Prescribing treatment without discussing behavior modification.
The fix: Counsel patients on:
Hair removal alternatives:
Laser hair removal (reduces folliculitis and eliminates need for daily shaving)
Electric trimmers instead of razors (less trauma)
Depilatory creams if tolerated (patch test first)
Friction reduction:
Looser-fitting clothing, especially during exercise
Moisture-wicking fabrics to reduce maceration
Anti-chafing products (silicone-based) if friction is unavoidable
Gentle cleansing:
Avoid scrubbing or using abrasive exfoliants
Cleanse with hands or soft cloth
Pat dry, don't rub
Topical therapy only works if the skin isn't being re-injured daily.
Axillary hyperpigmentation is dismissed too often as "cosmetic" or "not serious."
But it matters to patients and it should matter to providers.
Because:
It can signal undiagnosed metabolic disease
It's a common source of embarrassment and impacts quality of life
It's often iatrogenic (caused by harsh products or poor guidance)
It's treatable when approached systematically
The practices that take axillary darkening seriously and treat it with the same diagnostic rigor as facial melasma; build trust with patients who've been told "just live with it."
Trust is built when patients feel heard about concerns others have dismissed.
Practical Reset: Your Next Patient with Axillary Darkening
Before prescribing:
Step 1: Characterize the pattern
Texture: Flat (PIH) or velvety (AN)?
Distribution: Symmetric or asymmetric?
Onset: Gradual or sudden?
Step 2: Screen for systemic drivers
Check glucose, HbA1c, insulin if acanthosis nigricans is present
Rule out PCOS in reproductive-age women
Consider malignancy screening if sudden onset in older adult
Step 3: Identify and remove triggers
Product history (deodorant, soaps, fragrances)
Mechanical factors (shaving method, clothing friction)
Active inflammation or dermatitis
Step 4: Match treatment to etiology
PIH: azelaic acid, kojic acid, alpha arbutin, or short-course hydroquinone
AN: address insulin resistance + topical retinoid + keratolytics
Contact dermatitis: eliminate allergen/irritant + barrier repair
Step 5: Set expectations
Improvement takes 8-16 weeks minimum
Prevention requires ongoing friction reduction
Metabolic AN improves with systemic treatment, not just topicals
Small diagnostic discipline prevents treatment failure.
Evidence-Based Applications
We have created this FREE Guide for you:
Want to Go Deeper?
Take one of our modules
Here are our featured courses for today!
"The skin doesn't lie: it signals what's happening beneath. Our job is to listen before we treat."
— The Derm for Primary Care Team
👋🏻 See you next Thursday, DERM community!
Axillary hyperpigmentation is not a single condition.
It's a symptom that requires pattern recognition, systemic awareness, and individualized treatment.
When approached with diagnostic rigor (not reflexive prescribing) outcomes improve, patients feel heard, and trust deepens.
See you next Thursday, DERM Community, where we'll explore the evidence (and myths) around Aluminum in Deodorants.
Until then, stay curious and keep looking beneath the surface.
— The Derm for Primary Care Team
